Olaratumab

From Wikipedia, the free encyclopedia
Jump to: navigation, search
Olaratumab ?
Monoclonal antibody
Type Whole antibody
Source Human
Target PDGF-R α
Clinical data
Legal status investigational
Identifiers
CAS number 1024603-93-7 N
ATC code None
KEGG D09939 N
Chemical data
Formula C6554H10076N1736O2048S40 
Mol. mass 147.2 kDa
 N (what is this?)  (verify)

Olaratumab is a monoclonal antibody which is being developed by Imclone for the treatment of solid tumors. It is directed against the platelet-derived growth factor receptor alpha.[1]

References[edit]